The Future of Pharmacological Therapy for Risk Factor Reduction
- 1 January 1988
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 36 (3), 115-120
- https://doi.org/10.2165/00003495-198800363-00024
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society.1988
- Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic AcidActa Medica Scandinavica, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.1987
- SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MENThe Lancet, 1986
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.Heart, 1978